ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis
January 05, 2021SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon, informed the company. -
SPARC and Sun Pharma enter into license agreement for SCD-044
May 29, 2020Sun Pharma Advanced Research Company (SPARC) and Sun Pharmaceutical Industries announced a worldwide licensing agreement on the development and commercialisation of SCD-044.
Pharma Sources Insight January 2025
